Advertisement
Screener

AIM IMMUNOTECH INC. (AIM) Revenue from Contract with Customer, Excluding Assessed Tax

1.5 / 5 stars · 24/82 Roast Me

AIM IMMUNOTECH INC. Revenue from Contract with Customer, Excluding Assessed Tax

AIM IMMUNOTECH INC. (AIM) reported Revenue from Contract with Customer, Excluding Assessed Tax of $26.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Income Statement › Revenue

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-07

  • AIM IMMUNOTECH INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $26.00K, a 4.00% increase year-over-year.
  • AIM IMMUNOTECH INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $22.00K, a 37.50% increase year-over-year.
  • AIM IMMUNOTECH INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $21.00K, a 53.33% decline year-over-year.
  • AIM IMMUNOTECH INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $26.00K, a 25.71% decline year-over-year.
  • AIM IMMUNOTECH INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $88.00K, a 48.24% decline from fiscal 2024.
  • AIM IMMUNOTECH INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $170.00K, a 15.84% decline from fiscal 2023.
  • AIM IMMUNOTECH INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $202.00K, a 43.26% increase from fiscal 2022.
  • AIM IMMUNOTECH INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $141.00K, a 4.44% increase from fiscal 2021.
Period endRevenue from Contract with Customer, Excluding Assessed Tax 3 monthRevenue from Contract with Customer, Excluding Assessed Tax 6 monthRevenue from Contract with Customer, Excluding Assessed Tax 9 monthRevenue from Contract with Customer, Excluding Assessed Tax 12 month
2026-06-30$26.00K
10-Q · filed 2026-08-07
$48.00K
10-Q · filed 2026-08-07
$69.00K
derived: sum of 3 quarters · filed 2026-08-07
$95.00K
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$22.00K
10-Q · filed 2026-05-15
$43.00K
derived: sum of 2 quarters · filed 2026-05-15
$69.00K
derived: sum of 3 quarters · filed 2026-05-15
$94.00K
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$21.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
$47.00K
derived: sum of 2 quarters · filed 2026-03-27
$72.00K
derived: sum of 3 quarters · filed 2026-08-07
$88.00K
10-K · filed 2026-03-27
2025-09-30$26.00K
10-Q · filed 2025-11-17
$51.00K
derived: sum of 2 quarters · filed 2026-08-07
$67.00K
10-Q · filed 2025-11-17
$112.00K
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$25.00K
10-Q · filed 2026-08-07
$41.00K
10-Q · filed 2026-08-07
$86.00K
derived: sum of 3 quarters · filed 2026-08-07
$121.00K
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31$16.00K
10-Q · filed 2026-05-15
$61.00K
derived: sum of 2 quarters · filed 2026-05-15
$96.00K
derived: sum of 3 quarters · filed 2026-05-15
$146.00K
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31$45.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
$80.00K
derived: sum of 2 quarters · filed 2026-03-27
$130.00K
derived: sum of 3 quarters · filed 2026-03-27
$170.00K
10-K · filed 2026-03-27
2024-09-30$35.00K
10-Q · filed 2025-11-17
$85.00K
derived: sum of 2 quarters · filed 2025-11-17
$125.00K
10-Q · filed 2025-11-17
$190.00K
derived: sum of 4 quarters · filed 2025-11-17
2024-06-30$50.00K
10-Q · filed 2025-08-14
$90.00K
10-Q · filed 2025-08-14
$155.00K
derived: sum of 3 quarters · filed 2025-08-14
$201.00K
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$40.00K
10-Q · filed 2025-05-15
$105.00K
derived: sum of 2 quarters · filed 2025-05-15
$151.00K
derived: sum of 3 quarters · filed 2025-05-15
$193.00K
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$65.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
$111.00K
derived: sum of 2 quarters · filed 2025-03-27
$153.00K
derived: sum of 3 quarters · filed 2025-03-27
$202.00K
10-K · filed 2025-03-27
2023-09-30$46.00K
10-Q · filed 2024-11-14
$88.00K
derived: sum of 2 quarters · filed 2024-11-14
$137.00K
10-Q · filed 2024-11-14
$193.00K
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$42.00K
10-Q · filed 2024-08-14
$91.00K
10-Q · filed 2024-08-14
$147.00K
derived: sum of 3 quarters · filed 2024-08-14
$168.00K
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31$49.00K
10-Q · filed 2024-05-15
$105.00K
derived: sum of 2 quarters · filed 2024-05-15
$126.00K
derived: sum of 3 quarters · filed 2024-05-15
$156.00K
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$56.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
$77.00K
derived: sum of 2 quarters · filed 2024-04-01
$107.00K
derived: sum of 3 quarters · filed 2024-04-01
$141.00K
10-K · filed 2024-04-01
2022-09-30$21.00K
10-Q · filed 2023-11-14
$51.00K
derived: sum of 2 quarters · filed 2023-11-14
$85.00K
10-Q · filed 2023-11-14
$134.00K
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$30.00K
10-Q · filed 2023-08-14
$64.00K
10-Q · filed 2023-08-14
$113.00K
derived: sum of 3 quarters · filed 2023-08-14
$146.00K
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$33.00K
10-Q · filed 2023-05-15
$83.00K
derived: sum of 2 quarters · filed 2023-05-15
$116.00K
derived: sum of 3 quarters · filed 2023-05-15
$139.00K
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$50.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$83.00K
derived: sum of 2 quarters · filed 2023-03-31
$106.00K
derived: sum of 3 quarters · filed 2023-03-31
$135.00K
10-K · filed 2023-03-31
2021-09-30$33.00K
10-Q · filed 2022-11-14
$56.00K
derived: sum of 2 quarters · filed 2022-11-14
$85.00K
10-Q · filed 2022-11-14
$126.00K
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$23.00K
10-Q · filed 2022-08-15
$52.00K
10-Q · filed 2022-08-15
$93.00K
derived: sum of 3 quarters · filed 2022-08-15
$129.00K
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31$28.00K
10-Q · filed 2022-05-13
$70.00K
derived: sum of 2 quarters · filed 2022-05-13
$106.00K
derived: sum of 3 quarters · filed 2022-05-13
$146.00K
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31$42.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
$78.00K
derived: sum of 2 quarters · filed 2022-03-31
$118.00K
derived: sum of 3 quarters · filed 2022-03-31
$163.00K
10-K · filed 2022-03-31
2020-09-30$36.00K
10-Q · filed 2021-11-15
$76.00K
derived: sum of 2 quarters · filed 2021-11-15
$121.00K
10-Q · filed 2021-11-15
$171.00K
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30$40.00K
10-Q · filed 2021-08-16
$85.00K
10-Q · filed 2021-08-16
$135.00K
derived: sum of 3 quarters · filed 2021-08-16
$196.00K
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31$45.00K
10-Q · filed 2021-05-17
$95.00K
derived: sum of 2 quarters · filed 2021-05-17
$156.00K
derived: sum of 3 quarters · filed 2021-05-17
$185.00K
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31$50.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
$111.00K
derived: sum of 2 quarters · filed 2021-03-31
$140.00K
derived: sum of 3 quarters · filed 2021-03-31
$140.00K
10-K · filed 2021-03-31
2019-09-30$61.00K
10-Q · filed 2020-11-12
$90.00K
derived: sum of 2 quarters · filed 2020-11-12
$90.00K
10-Q · filed 2020-11-12
2019-06-30$29.00K
10-Q · filed 2020-08-14
$29.00K
10-Q · filed 2020-08-14
2018-12-31$240.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30
$278.00K
derived: sum of 2 quarters · filed 2020-03-30
$311.00K
derived: sum of 3 quarters · filed 2020-03-30
$367.00K
10-K · filed 2020-03-30
2018-09-30$38.00K
10-Q · filed 2019-11-14
$71.00K
derived: sum of 2 quarters · filed 2019-11-14
$127.00K
10-Q · filed 2019-11-14
2018-06-30$33.00K
10-Q · filed 2019-08-14
$89.00K
10-Q · filed 2019-08-14
2018-03-31$56.00K
10-Q · filed 2019-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Silexion Therapeutics Corp (SLXN)$0.001B